We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Verastem
VSTM
$530M
| – | – |
-1,055,389
| Closed | -$9.32M |
|
3502
VirTra
VTSI
$35.1M
| – | – |
-143,717
| Closed | -$756K |
|
|
VTYX
3503
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-2,316,275
| Closed | -$7.2M |
|
3504
Vuzix
VUZI
$188M
| – | – |
-98,602
| Closed | -$309K |
|
|
VXRT
3505
DELISTED
Vaxart
VXRT
| – | – |
-1,953,037
| Closed | -$703K |
|
3506
PUT
Verizon
VZ
$182B
| – | – |
-750,000
| Closed | -$33M |
|
3507
Wabtec
WAB
$44.5B
| – | – |
-30,801
| Closed | -$6.17M |
|
3508
WaFd
WAFD
$2.82B
| – | – |
-47,950
| Closed | -$1.45M |
|
3509
Welltower
WELL
$172B
| – | – |
-172,775
| Closed | -$30.8M |
|
3510
Winnebago Industries
WGO
$868M
| – | – |
-21,400
| Closed | -$716K |
|
3511
GeneDx Holdings
WGS
$1.88B
| – | – |
-8,488
| Closed | -$914K |
|
3512
WhiteHorse Finance
WHF
$139M
| – | – |
-65,850
| Closed | -$456K |
|
3513
CALL
Wingstop
WING
$3.88B
| – | – |
-3,500
| Closed | -$881K |
|
|
3514
PUT
Wingstop
WING
$3.88B
| – | – |
-2,500
| Closed | -$629K |
|
3515
Westlake Corp
WLK
$9.95B
| – | – |
-56,461
| Closed | -$4.35M |
|
3516
Waste Management
WM
$96.1B
| – | – |
-114,146
| Closed | -$25.2M |
|
3517
PUT
Walmart Inc
WMT
$909B
| – | – |
-4,500
| Closed | -$464K |
|
|
WNS
3518
DELISTED
WNS Holdings
WNS
| – | – |
-188,470
| Closed | -$14.4M |
|
3519
Worthington Enterprises
WOR
$2.75B
| – | – |
-82,912
| Closed | -$4.6M |
|
3520
Waterstone Financial
WSBF
$355M
| – | – |
-28,431
| Closed | -$444K |
|
3521
Williams-Sonoma
WSM
$26.9B
| – | – |
-39,883
| Closed | -$7.8M |
|
3522
Watts Water Technologies
WTS
$11.6B
| – | – |
-1,662
| Closed | -$464K |
|
3523
PUT
Willis Towers Watson
WTW
$27.7B
| – | – |
-6,200
| Closed | -$2.14M |
|
3524
Wave Life Sciences
WVE
$1.12B
| – | – |
-14,000
| Closed | -$102K |
|
3525
Woodward
WWD
$23.4B
| – | – |
-2,912
| Closed | -$736K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.